Covered recipient · General Payments record
MALLORIE EMORY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2023–2024
$1,717.30
- Reported across 81 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,132.75 | 65 |
| Education | $303.81 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $249.66 | 19 |
| PFIZER INC. | $213.08 | 9 |
| Lilly USA, LLC | $103.83 | 1 |
| SEAGEN INC. | $99.99 | 1 |
| Genentech USA, Inc. | $82.00 | 4 |
| Janssen Biotech, Inc. | $74.27 | 3 |
| ABBVIE INC. | $65.50 | 3 |
| Incyte Corporation | $56.94 | 3 |
| EISAI INC. | $48.22 | 2 |
| PharmaEssentia USA Corporation | $45.80 | 2 |
| Acerta Pharma LLC | $42.46 | 2 |
| Merck Sharp & Dohme Corporation | $35.81 | 2 |
| ARRAY BIOPHARMA INC | $30.07 | 2 |
| E.R. Squibb & Sons, L.L.C. | $30.06 | 2 |
| Octapharma USA, Inc. | $26.13 | 1 |
| EMD Serono, Inc. | $25.16 | 1 |
| TerSera Therapeutics LLC | $24.80 | 1 |
| TAIHO ONCOLOGY, INC. | $23.50 | 1 |
| Karyopharm Therapeutics Inc. | $21.56 | 1 |
| Exelixis Inc. | $21.20 | 1 |
| Ipsen Biopharmaceuticals, Inc | $20.66 | 1 |
| Myriad Genetic Laboratories, Inc. | $18.60 | 1 |
| Rigel Pharmaceuticals, Inc. | $16.64 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16.25 | 1 |
| Alexion Pharmaceuticals, Inc. | $16.10 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $14.40 | 1 |
| Pharmacosmos Therapeutics Inc. | $13.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (68)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.